Although either medications manage articular discomfort , Novera Retatrutide represents a injectable designed obesity , working through dual mechanisms . Unlike, HylaneX remains the viscoelastic substance therapy largely deployed within alleviate osteoarthritis symptoms in the knee . Thus , these indications and therapeutic strategies seem fundame